HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom. Antivir Ther. 15:985-91.. 2010.
HIV Virulence has not increased in the UK subtype B epidemic. Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014.. 2014.
HIV-1 drug resistance in HIV-1-infected children in the United Kingdom from 1998 to 2004. Pediatr Infect Dis J. 27:457-9.. 2008.
HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK. J Antimicrob Chemother. 71(12). 2016.
HIV-1 subtype and virological response to antiretroviral therapy: a confirmatory analysis. Clin Infect Dis. 56:162-3.. 2013.
The HIV-1 subtype C epidemic in South America is linked to the United Kingdom. PLoS One. 5:e9311.. 2010.
HIV-1 transmission patterns in men who have sex with men: insights from genetic source attribution analysis.. AIDS Res Hum Retroviruses.. 2019.
How common is the mutation E138K in the UK? 18th Annual Conference of the British HIV Association, 18-20 April 2012.. 2012.
Identification of accessory mutations associated with high-level resistance in HIV-1 reverse transcriptase. AIDS. 21:447-55.. 2007.
Identifying the sources of recent HIV infection in a UK cohort. 24th International HIV Dynamics and Evolution.. 2017.
The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the United Kingdom. J Acquir Immune Defic Syndr. 49:196-204.. 2008.
The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the UK. 13th Annual Conference of the British HIV Association, 25-28 April 2007.. 2007.
The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the UK. 2nd International Workshop on HIV Transmission, 26-28 August 2007.. 2007.
The impact of HIV drug resistance testing on changes to treatment. AIDS. 25:603-10.. 2011.
The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults. AIDS. 27:2245-53.. 2013.
Impact of HIV-1 subtype on genotypic resistance to protease inhibitors in the United Kingdom. 13th Conference on Retroviruses and Opportunistic Infections, 5-8 February 2006.. 2006.
The impact of resistance testing in ARV-naive patients: does it guide optimal therapy selection and improve long-term outcomes? British HIV Association 14th Annual Conference, 23-25 April 2008.. 2008.
The impact of structural and functional constraints acting at the nucleic acid level on the evolution of drug resistance in HIV-1. 15th International HIV Drug Resistance Workshop, 13-17 June 2006.. 2006.
The impact of the 0-0 cell on measures of amino acid covariation. AIDS. 24:159-60.. 2010.
Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART). J Acquir Immune Defic Syndr. 53:633-9.. 2010.